|
LENG9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65178981603731E-12 |
| Normal-vs-Stage2 |
2.699200E-03 |
| Normal-vs-Stage3 |
1.499190E-03 |
| Normal-vs-Stage4 |
2.140700E-03 |
| Stage1-vs-Stage2 |
6.723700E-02 |
| Stage1-vs-Stage3 |
5.316700E-03 |
| Stage1-vs-Stage4 |
9.008400E-01 |
| Stage2-vs-Stage3 |
6.212800E-01 |
| Stage2-vs-Stage4 |
2.608600E-01 |
| Stage3-vs-Stage4 |
9.734200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
7.22330000035853E-07 |
| Normal-vs-Asian |
6.357700E-02 |
| Caucasian-vs-AfricanAmerican |
3.813600E-01 |
| Caucasian-vs-Asian |
1.679410E-01 |
| AfricanAmerican-vs-Asian |
1.194030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.71269999960089E-07 |
| Male-vs-Female |
3.686800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.60519999997866E-06 |
| Normal-vs-Extreme_Weight |
1.66533453693773E-15 |
| Normal-vs-Obese |
2.94090000019231E-07 |
| Normal-vs-Extreme_Obese |
1.698190E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.617600E-01 |
| Normal_Weight-vs-Obese |
8.300400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.909800E-02 |
| Extreme_Weight-vs-Obese |
9.241400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.330100E-02 |
| Obese-vs-Extreme_Obese |
6.796400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.817500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.67554858876429E-12 |
| Normal-vs-Age(61-80Yrs) |
7.21644966006352E-14 |
| Normal-vs-Age(81-100Yrs) |
6.423800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.108400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.626000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.411200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.336800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.961610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.871840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
7.837100E-04 |
| Normal-VS-KIRP CIMP |
1.117590E-01 |
| Normal-VS-Unclassified PRCC |
8.11569999999984E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.89309695592033E-11 |
| Type1 PRCC-VS-KIRP CIMP |
8.744300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.386600E-04 |
| Type2 PRCC-VS-KIRP CIMP |
3.956800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.646400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.765800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.966699999997E-05 |
| Normal-vs-N1 |
2.140100E-03 |
| Normal-vs-N2 |
2.655400E-01 |
| N0-vs-N1 |
8.674400E-01 |
| N0-vs-N2 |
9.830600E-01 |
| N1-vs-N2 |
9.117400E-01 |
|
|
